Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Magnesium Loss In Patients Given Monoclonal Antibodies

02.05.2007
97% of patients with cancer treated with monoclonal antibodies—cetuximab, matuzumab, or panitumumab—that target the epidermal growth factor receptor (EGFR) have some degree of magnesium loss (hypomagnesaemia), according to a study published today in the May issue of THE LANCET ONCOLOGY.

“Our study is important because it shows that magnesium wasting will occur in all patients…[Previously,] hypomagnesaemia was thought to be restricted to an undefined subset of patients”, says lead author Prof Sabine Tejpar. “Predicting the risk of hypomagnesaemia will also be important in those patients receiving combination treatments with nephrotoxic and potential magnesium-wasting agents, such as cisplatin.”

Previous retrospective studies had shown severe magnesium loss (grades 3 and 4 hypomagnesaemia) in only a small proportion of patients given anti-EGFR drugs and whether all or a subset of patients are affected was unknown. Hypomagnesaemia is a serious side-effect of treatment as it can cause dizziness, weakness, cardiac abnormalities, or even generalised convulsions. Furthermore, agents against EGFR are being used increasingly to treat solid tumours, in particular cancers of the colorectum. However, the extent of this side-effect in patients given these antibodies has not previously been fully assessed.

Prof Sabine Tejpar and colleagues therefore studied prospectively the degree of hypomagnesaemia in 98 patients with metastatic colorectal cancer treated with these antibodies. 95 (97%) of patients had decreased serum magnesium concentrations during treatment with the EGFR-targeted antibodies compared with baseline measures (mean serum magnesium slope –0•00157 mmol/L/day [95% CI –0•00191 to –0•00123]) and this change was significantly lower than that seen in the control group not receiving antibody treatment—ie, given chemotherapy alone (0•00014 mmol/L/day [–0•00026 to 0•00055]).

In an accompanying comment, Dr Marwan Fakih (Roswell Park Cancer Institute, NY, USA) discusses the implications of the study data for clinical practice, commenting that patient characteristics, in terms of age, baseline magnesium concentrations, and duration of treatment, could help in the early identification of those at high risk. He suggests there are still a number of unanswered questions, such as whether the magnesium concentration slope could be used to predict the time at which clinically significant hypomagnesaemia will occur, and he indicates that validation of The Lancet Oncology data in a larger prospective study could help in the development of a model that accurately predicts those who are most at risk of severe hypomagnesaemia and candidates for monitoring and early intervention. In addition, Fakih proposes that intermittent treatment schedules could be appropriate for those at high risk.

The authors agree with Dr Fakih that identification of these high-risk patients is important and conclude that their study suggests a pivotal role of the EGFR-signalling pathway in regulating magnesium homeostasis: “Our study might pave the way for future therapeutic intervention to treat hypomagnesaemia and modulate or prevent its occurrence”.

Tony Kirby | alfa
Further information:
http://www.lancet.com

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Thanks for the memory: NIST takes a deep look at memristors

22.01.2018 | Materials Sciences

Radioactivity from oil and gas wastewater persists in Pennsylvania stream sediments

22.01.2018 | Earth Sciences

Saarland University bioinformaticians compute gene sequences inherited from each parent

22.01.2018 | Life Sciences

VideoLinks Wissenschaft & Forschung
Overview of more VideoLinks >>>